BALOTTA, CLAUDIA
BALOTTA, CLAUDIA
Dipartimento di Scienze Biomediche e Cliniche
A marked decrease of HIV 1 viremia in a population of potential transmitters in the 1997-2007 interval reduced the proportion of acute seroconverters but minimally affected the transmission of drug resistance
2009 A. Lai, M. Franzetti, M. Violin, V. Micheli, A. Capetti, M.R. Gismondo, G. Rizzardini, M. Galli, C. Balotta
A Simple model of HIV epidemic in Italy: The role of the antiretroviral treatment
2018 F. Papa, F. Binda, G. Felici, M. Franzetti, A. Gandolfi, C. Sinisgalli, C. Balotta
Acute Seroconvertions but not transmission of drug resistance is decreasing as effect of a marked reduction of HIV-1 viremia in a population of potential transmitters over the last 10 years
2009 M. Franzetti, A. Violin, M. Micheli, A. Capetti, M.R. Gismondo, G. Rizzardini, G. Galli, G. Casazza, C. Balotta
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+ subpopulation
1996 C. Negri, S. Rusconi, A. Gori, C. Riva, C. Balotta, M. Galli
An International Collaboration To Standardize HIV-2 Viral Load Assays : Results from the 2009 ACHIEV2E Quality Control Study
2011 F. Damond, A. Benard, C. Balotta, J. Böni, M. Cotten, V. Duque, B. Ferns, J. Garson, P. Gomes, F. Gonçalves, G. Gottlieb, B. Kupfer, J. Ruelle, B. Rodes, V. Soriano, M. Wainberg, A. Taieb, S. Matheron, G. Chene, F. Brun-Vezinet
An outbreak of HIV-1 BC recombinants in Southern Italy
2012 L. Monno, G. Brindicci, A. Lai, G. Punzi, M. Altamura, F.R. Simonetti, N. Ladisa, A. Saracino, C. Balotta, G. Angarano
An outbreak of HIV-1 subtype G among Italian injecting drug users
2007 M. Ciccozzi, S. Montieri, M. Salemi, T. De Oliveira, M. Dorrucci, A. Sinicco, A. De Luca, M. Giuliani, C. Balotta, G. Rezza
Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy
1989 C Chiabrando, MG Castelli, E Cozzi, R Fanelli, A Campoleoni, C Balotta, R Latini, S Garattini
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages
1993 C. Balotta, P. Lusso, R. Crowley, R. Gallo, G. Franchini
Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients
1990 G. Girasole, J. Wang, M. Pedrazzoni, G. Pioli, C. Balotta, M. Passeri, A. Lazzarin, A. Ridolfo, A. Mantovani
CD4 count in HIV infection is positively correlated to interferon-gamma and negatively correlated to interleukin-10 in vitro production
1996 A. Salvaggio, C. Balotta, M. Galli, M. Clerici
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe
2010 V.L. Demetriou, D.A. van de Vijver, I. Kousiappa, C. Balotta, B. Clotet, Z. Grossman, L.B. Jørgensen, S.Z. Lepej, I. Levy, C. Nielsen, D. Paraskevis, M. Poljak, F. Roman, L. Ruiz, J.C. Schmidt, A.M. Vandamme, K. Van Laethem, J. Vercauteren, L.G. Kostrikis
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades
2010 A. Lai, C. Riva, A. Marconi, M. Balestrieri, F. Razzolini, G. Meini, I. Vicenti, A. Rosi, F. Saladini, I.C. Caramma, M. Franzetti, V. Rossini, A. Galli, M. Galli, M. Violin, M. Zazzi, C. Balotta
Chemokine production in HIV-seropositive long-term asymptomatic individuals
1996 M. Clerici, C. Balotta, D. Trabattoni, L. Papagno, S. Ruzzante, S. Rusconi, M.L. Fusi, M.C. Colombo, M. Galli
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice
1987 A. Benomar, W. Ming, G. Taraboletti, P. Ghezzi, C. Balotta, G. Cianciolo, R. Snyderman, J. Doré, A. Mantovani
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021
2021 A. Lai, A. Bergna, S. Menzo, G. Zehender, S. Caucci, V. Ghisetti, F. Rizzo, F. Maggi, F. Cerutti, G. Giurato, A. Weisz, C. Turchi, B. Bruzzone, F. Ceccherini Silberstein, N. Clementi, A. Callegaro, F. Sagradi, D. Francisci, E. Venanzi Rullo, I. Vicenti, M. Clementi, M. Galli, C. Balotta, M. Gori, P. Bagnarelli, A. Baj, F. Novazzi, A. Orsi, P. Caligiuri, S. Boccotti, M.C. Bellocchi, L. Sarmati, M. Andreoni, N. Mancini, E. Criscuolo, R. Gallitelli, S. Testa, F. Dragoni, M. Zazzi
Clinical and immunological aspects of HIV infection in drug addicts
1989 M. Galli, A. Lazzarin, A. Saracco, C. Balotta, A. Castagna, C. Negri, A.L. Ridolfo, C. Uberti Foppa, M. Corbellino, M. Moroni
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection
1998 A. d'Arminio Monforte, L. Testa, F. Adorni, E. Chiesa, T. Bini, G. Moscatelli, C. Abeli, S. Rusconi, S. Sollima, C. Balotta, M. Musicco, M. Galli, M. Moroni
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals
1997 C. Balotta, P. Bagnarelli, C. Riva, A. Valenza, S. Antinori, M.C. Colombo, R. Sampaolesi, M.B. Violin, M.P. de Pasquale, M. Moroni, M. Clementi, M. Galli
Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors
2002 L. Papagno, V. Appay, J. Sutton, T. Rostron, G. Gillespie, G. Ogg, A. King, A. Makadzanhge, A. Waters, C. Balotta, A. Vyakarnam, P. Easterbrook, S. Rowland Jones